VANTA BIOSCIENCE L...● IPO DETAIL◆ GMPNIL◆ STATUSListed◆ IPOCloudTrack Every IPO◆ VANTA BIOSCIENCE L...● IPO DETAIL◆ GMPNIL◆ STATUSListed◆ IPOCloudTrack Every IPO◆
Live GMP
Back to IPOs
VB

Vanta Bioscience Ltd

BSE SME · SME IPO
Listed BSE SME SME Live Chart
Issue Price
₹50
₹50
GMP (Grey Market)
NIL
Unofficial data only
Est. Listing Price
₹50
Based on GMP
Min. Investment
₹150,000
1 lot × 3000 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
25 Sep 2017
Close Date
27 Sep 2017
Allotment
03 Oct 2017
Listing Date
06 Oct 2017
Exchange
BSE SME
Price Band
₹50
Listing Price
See chart
Allotment Status
Price Band
₹50
Per share
Face Value
₹10 per share
 
Lot Size
3,000 Shares
per lot
Issue Size
15,12,000 shares (aggregating up to ₹7.56 Cr)
Total offering
Issue Type
Fixed Price IPO
 
Min Investment
₹150,000
1 lot
Pre-IPO Holding
42,16,000 shares
Promoters
Post-IPO Holding
57,28,000 shares
Promoters
UPI Deadline
2017-09-27
Mandate
Anchor AllotmentSun, 24 Sep 2017
Basis of AllotmentTue, 03 Oct 2017
Refund InitiationWed, 04 Oct 2017
Demat CreditWed, 04 Oct 2017
Listing DayFri, 06 Oct 2017
UPI Mandate Deadline2017-09-27
Sale TypeFresh Capital
Net Offer to Public14,34,000 shares (aggregating up to ₹7.17 Cr)
Market Maker Quota78,000 shares (aggregating up to ₹0.3900 Cr)
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
NSE ListingView on NSE →
Check AllotmentClick here →
Subscription Rate Final
Vanta Bioscience Ltd IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 27 Sep 2017.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
Market Maker
Awaited
78,000
— ₹0.39
QIB
Over 1.00x
— — —
NII / HNI
Over 1.00x
— — —
Retail
Over 1.00x
— — —
Total 1.00x
1,512,000
100% ₹7.56
IPO Shares Offered
Vanta Bioscience Ltd IPO total issue size: ₹7.56 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Market Maker 78,000 ₹0.39
5.16%
Total 1,512,000 ₹7.56
100.00%
* Based on upper price band ₹50 per share
Lot Size & Investment
Lot Size
3,000
Shares per Lot
Issue Price
₹50.00
Upper Band
Min Investment
₹150,000
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)26,000₹300,000
Retail (Max — 13 Lots)1339,000₹1,950,000
S-HNI (Min — 14 Lots)1442,000₹2,100,000
B-HNI (Min — 68 Lots)68204,000₹10,200,000
* Issue Price ₹50 × Lot Size 3,000 shares
IPO Schedule
Anchor
24 Sep 2017
✓ Done
IPO Open
25 Sep 2017
✓ Done
IPO Close
27 Sep 2017
✓ Done
Allotment
03 Oct 2017
✓ Done
Refunds
04 Oct 2017
✓ Done
Demat Credit
04 Oct 2017
✓ Done
Listing Day
06 Oct 2017
✓ Done
Vanta Bioscience Ltd — Live Price LIVE
₹50.00
INR · BSE
Fetching…
vs Issue Price
—
OPEN
—
HIGH
—
LOW
—
MKT CAP
—
P/E
—
52W HIGH
—
52W LOW
—
VOLUME
—
DIVIDEND
—
DIV YIELD
—
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹50.00 Live Price
About Vanta Bioscience Ltd
Incorporated in 1995, Vanta Bioscience Ltd (VBL) is a preclinical contract research company which offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.In addition they also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBL also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.One of the major services of VBL is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Toxicology and safety assessment are sometimes used interchangeably and considered as synonymous.Vanta Bioscience based in Des Moines, Iowa with additional offices in Brussels, Belgium; and West Des Moines, Iowa. It has a toxicology research facility in Chennai, India.
Objects of the Issue
1
Augmenting additional working capital requirements
2
General Corporate Purposes
Vanta Bioscience Ltd Financials (Amount in ₹ Lakhs)
Revenue from Operations
N/A
FY 2022-23
N/A
FY 2023-24
N/A
31-Mar-2017
Profit After Tax (PAT)
N/A
FY 2022-23
N/A
FY 2023-24
N/A
31-Mar-2017
Particulars31-Mar-2017FY 2023-24FY 2022-23
Revenue from Operations N/A N/A N/A
EBITDA N/A N/A N/A
Profit After Tax (PAT) N/A N/A N/A
Net Worth N/A N/A N/A
Total Assets 1374.59 N/A N/A
Reserves & Surplus 364.60 N/A N/A
Borrowings 750.54 N/A N/A
EBITDA Margin (%) N/A — —
PAT Margin (%) N/A — —
Financial data will be published once DRHP/RHP is filed with SEBI.
Issue Structure & Shareholding
Total Shares Offered15,12,000 (100.00%)
Net Offer to Public14,34,000 shares (aggregating up to ₹7.17 Cr)
Reserved for Market Maker78,000 shares (aggregating up to ₹0.3900 Cr)
Pre-Issue Promoter Holding42,16,000 shares
Post-Issue Promoter Holding57,28,000 shares
P/BV RatioN/A
RoEN/A
RoCEN/A
Debt / EquityN/A
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
INVENTURE MERCHANT BANKER SERVICES PRIVATE LIMITED
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Vanta Bioscience Ltd IPO subscribed? ▲

Vanta Bioscience Ltd IPO is subscribed 1.00 times by Sep 27, 2017. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Vanta Bioscience Ltd IPO retail subscription status? ▼

The Vanta Bioscience Ltd IPO retail category is subscribed 1.00 times as of 27 Sep 2017. The retail portion is oversubscribed.

How to subscribe Vanta Bioscience Ltd IPO? ▼

Subscribe via your broker app using ASBA or UPI. Opens 25 Sep 2017 and closes 27 Sep 2017. Min investment: ₹150,000 (1 lot = 3,000 shares). UPI mandate: 2017-09-27.

How many times Vanta Bioscience Ltd IPO subscribed? ▼

The Vanta Bioscience Ltd IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Vanta Bioscience Ltd IPO allotment? ▼

Check allotment on the registrar website (Bigshare Services Pvt.Ltd.) at https://ipo.bigshareonline.com/IPO_Status.html. Enter your PAN, application number or DP/Client ID. Allotment date: 03 Oct 2017. Refunds: on 04 Oct 2017.

When Vanta Bioscience Ltd IPO will be listed? ▼

The Vanta Bioscience Ltd IPO listing date is 06 Oct 2017, Friday. Listed on: BSE SME. Issue price: ₹50. Estimated listing: ₹50. GMP: NIL.

When Vanta Bioscience Ltd IPO close? ▼

The Vanta Bioscience Ltd IPO closes on 27 Sep 2017, Wednesday. UPI mandate: 2017-09-27. Allotment: 03 Oct 2017. Listing: 06 Oct 2017.